Publication:
Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children

dc.contributor.authorWin Lai Mayen_US
dc.contributor.authorMyat Phone Kyawen_US
dc.contributor.authorStuart D. Blacksellen_US
dc.contributor.authorSasithon Pukrittayakameeen_US
dc.contributor.authorKesinee Chotivanichen_US
dc.contributor.authorBorimas Hanboonkunupakarnen_US
dc.contributor.authorKhin Nyo Theinen_US
dc.contributor.authorChae Seung Limen_US
dc.contributor.authorJanjira Thaipadungpaniten_US
dc.contributor.authorThomas Althausen_US
dc.contributor.authorPodjanee Jittamalaen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.contributor.otherKorea Universityen_US
dc.contributor.otherUniversity of Medicine 2en_US
dc.date.accessioned2020-01-27T07:30:57Z
dc.date.available2020-01-27T07:30:57Z
dc.date.issued2019-01-01en_US
dc.description.abstract© 2019 May et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Glucose-6-phosphate dehydrogenase (G6PD) deficiency may affect the clinical presentation of dengue due to the altered redox state in immune cells. We aimed to determine the association between G6PD deficiency and severity of dengue infection in paediatric patients in Myanmar. A cross-sectional study was conducted among paediatric patients aged 2–13 years with dengue in Yankin Children Hospital, Myanmar. One hundred and ninety-six patients positive for dengue infection, as determined via PCR or ELISA, were enrolled. Dengue severity was determined according to the 2009 WHO classification guidelines. Spectro-photometric assays determined G6PD levels. The adjusted median G6PD value of males in the study population was used to define various cut-off points according to the WHO classification guidelines. G6PD genotyping for Mahidol, Kaiping and Mediterranean mutations was performed for 128 out of 196 samples by real-time multiplex PCR. 51 of 196 (26.0%) patients had severe dengue. The prevalence of G6PD phenotype deficiency (< 60% activity) in paediatric patients was 14.8% (29/196), specifically, 13.6% (14/103) in males and 16.2% (15/93) in females. Severe deficiency (< 10% activity) accounted for 7.1% (14/196) of our cohort, occurring 11.7% (12/103) in males and 2.2% (2/93) in females. Among 128 samples genotyped, the G6PD gene mutations were detected in 19.5% (25/128) of patients, with 20.3% (13/ 64) in males and 18.8% (12/64) in females. The G6PD Mahidol mutation was 96.0% (24/25) while the G6PD Kaiping mutation was 4.0% (1/25). Severe dengue was not associated with G6PD enzyme deficiency or presence of the G6PD gene mutation. Thus, no association between G6PD deficiency and dengue severity could be detected.en_US
dc.identifier.citationPLoS ONE. Vol.14, No.1 (2019)en_US
dc.identifier.doi10.1371/journal.pone.0209204en_US
dc.identifier.issn19326203en_US
dc.identifier.other2-s2.0-85059502592en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/49920
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85059502592&origin=inwarden_US
dc.subjectAgricultural and Biological Sciencesen_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleImpact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar childrenen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85059502592&origin=inwarden_US

Files

Collections